More recently, a multi-center study, based on 658 men with PSA levels of 4 to 10 ng/mL, showed that phi outperformed free and total PSA for prostate cancer detection and improved the prediction of high-grade, clinically-significant prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.